Based on recent data, Acurx Pharmaceuticals, Inc. (ACXP) shows an Average True Range (ATR) of 0.2 and an Enterprise Value of 21.9M. Its average trading volume over the past 3 months is 3.33M, indicating liquidity. These fundamental metrics provide insight into ACXP's underlying financial health and market activity.
| ATR | 0.2 |
| Enterprise Value | 21.9M |
| Avg Vol (3 Months) | 3.33M |
| Avg Vol (10 Days) | 102.42K |
Acurx Pharmaceuticals, Inc. (ACXP) technical indicators as of May 12, 2026: the SMA 20 is -17.46%, SMA 50 at -36.18%, and SMA 200 at -69.43%. The RSI 14 value is 27.12, suggesting its current momentum. These technical analysis signals help assess ACXP's price trends and potential future movements.
| SMA 20 | -17.46% |
| SMA 50 | -36.18% |
| SMA 200 | -69.43% |
| RSI 14 | 27.12 |
Acurx Pharmaceuticals, Inc. (ACXP) stock performance overview as of May 12, 2026: The 52-week high is $21 (currently -92.19% below), and the 52-week low is $1.33 (currently 16.31% above). Over the past year, ACXP's performance is -83.8%, compared to the S&P 500's 16.69% change.
| 52-Week High | 21 |
| 52-Week High Chg | -92.19% |
| 52-Week Low | 1.33 |
| 52-Week Low Chg | +16.31% |
| S&P 500 52-Week Chg | 16.69% |
According to market data, Acurx Pharmaceuticals, Inc. (ACXP) stock's recent performance metrics show that over the last month, ACXP is -27.14%, with a Year-to-Date (YTD) performance of 2.41%. Over the past year, the stock has seen a -83.8% change. These figures summarize ACXP's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.19 | 3.13 | 7.54 | 7.54 | 21 | 7.54 |
| Low | 1.94 | 1.94 | 1.33 | 1.33 | 1.33 | 1.33 |
| Performance | -8.27% | -27.14% | -62.50% | -70.08% | -83.80% | +2.41% |
According to current financial data, ACXP stock's P/E (TTM) ratio is -0.41, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for ACXP, including P/S (N/A), P/B (0.62), and P/FCF (0.00), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ACXP | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.41 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 0.62 | 5.34 | 7.1 | 4.59 |
| P/FCF (TTM) | 0 | -2.88 | -424.95 | 31.91 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep